Your browser doesn't support javascript.
Virucidal efficacy of different formulations for hand and surface disinfection targeting SARS CoV-2.
Steinhauer, K; Meister, T L; Todt, D; Krawczyk, A; Paßvogel, L; Becker, B; Paulmann, D; Bischoff, B; Eggers, M; Pfaender, S; Brill, F H H; Steinmann, E.
  • Steinhauer K; Department Research & Scientific Services, Schülke & Mayr GmbH, Norderstedt, Germany; Faculty of Mechanical Engineering, Kiel University of Applied Sciences, Kiel, Germany. Electronic address: katrin.steinhauer@schuelke-mayr.com.
  • Meister TL; Department of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
  • Todt D; Department of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany; European Virus Bioinformatics Center, Jena, Germany.
  • Krawczyk A; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Paßvogel L; Department Research & Scientific Services, Schülke & Mayr GmbH, Norderstedt, Germany.
  • Becker B; Dr. Brill + Partner GmbH Institut for Hygiene and Microbiology, Hamburg, Germany.
  • Paulmann D; Dr. Brill + Partner GmbH Institut for Hygiene and Microbiology, Hamburg, Germany.
  • Bischoff B; Dr. Brill + Partner GmbH Institut for Hygiene and Microbiology, Hamburg, Germany.
  • Eggers M; Labor Prof. Gisela Enders MVZ GbR, Stuttgart, Germany.
  • Pfaender S; Department of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
  • Brill FHH; Dr. Brill + Partner GmbH Institut for Hygiene and Microbiology, Hamburg, Germany.
  • Steinmann E; Department of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
J Hosp Infect ; 112: 27-30, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1261926
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
In the ongoing SARS CoV-2 pandemic, effective disinfection measures are needed, and guidance based on the methodological framework of the European Committee for Standardization (CEN) may enable the choice of effective disinfectants on an immediate basis. This study aimed to elucidate whether disinfectants claiming 'virucidal activity against enveloped viruses' as specified in the European Standard EN 14476 as well as in the German Association for the Control of Viral Diseases/Robert Koch Institute (DVV/RKI) guideline are effectively inactivating SARS-CoV-2. Two commercially available formulations for surface disinfection and one formulation for hand disinfection were studied regarding their virucidal activity. Based on the data of this study the enveloped SARS-CoV-2 is at least equally susceptible compared to the standard test virus vaccinia used in the EN 14476 and DVV/RKI guidelines. Thus, chemical disinfectants claiming 'virucidal activity against enveloped viruses' based on the EN 14476 and DVV/RKI guidelines will be an effective choice to target enveloped SARS-CoV-2 as a preventive measure.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Disinfection / Hand Disinfection / Disinfectants / SARS-CoV-2 Topics: Vaccines Limits: Humans Language: English Journal: J Hosp Infect Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Disinfection / Hand Disinfection / Disinfectants / SARS-CoV-2 Topics: Vaccines Limits: Humans Language: English Journal: J Hosp Infect Year: 2021 Document Type: Article